155 related articles for article (PubMed ID: 29615702)
1. Global Proteomics Deciphered Novel-Function of Osthole Against Pulmonary Arterial Hypertension.
Yao L; Yang Y; He G; Ou C; Wang L; Liu K
Sci Rep; 2018 Apr; 8(1):5556. PubMed ID: 29615702
[TBL] [Abstract][Full Text] [Related]
2. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
3. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
[TBL] [Abstract][Full Text] [Related]
4. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
5. Osthole alleviates pulmonary vascular remodeling by modulating microRNA-22-3p mediated lipid metabolic reprogramming.
Niu Z; Fu M; Li Y; Ren H; Zhang X; Yao L
Phytomedicine; 2022 Feb; 96():153840. PubMed ID: 34836745
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
8. Osthole relaxes pulmonary arteries through endothelial phosphatidylinositol 3-kinase/Akt-eNOS-NO signaling pathway in rats.
Yao L; Lu P; Li Y; Yang L; Feng H; Huang Y; Zhang D; Chen J; Zhu D
Eur J Pharmacol; 2013 Jan; 699(1-3):23-32. PubMed ID: 23220709
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
10. Osthole attenuates pulmonary arterial hypertension by the regulation of sphingosine 1-phosphate in rats.
Yao L; Yang YX; Cao H; Ren HH; Niu Z; Shi L
Chin J Nat Med; 2020 Apr; 18(4):308-320. PubMed ID: 32402408
[TBL] [Abstract][Full Text] [Related]
11. Osthole attenuates pulmonary arterial hypertension in monocrotaline‑treated rats.
Li Y; Wang Y; Li Y; Qian Z; Zhu L; Yang D
Mol Med Rep; 2017 Sep; 16(3):2823-2829. PubMed ID: 28677726
[TBL] [Abstract][Full Text] [Related]
12. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
[TBL] [Abstract][Full Text] [Related]
13. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension.
de Raaf MA; Beekhuijzen M; Guignabert C; Vonk Noordegraaf A; Bogaard HJ
Reprod Toxicol; 2015 Aug; 56():45-51. PubMed ID: 26111581
[TBL] [Abstract][Full Text] [Related]
15. Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.
Thompson AAR; Lawrie A
Trends Mol Med; 2017 Jan; 23(1):31-45. PubMed ID: 27989641
[TBL] [Abstract][Full Text] [Related]
16. Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1α In Vitro and In Vivo.
Cheng CC; Chi PL; Shen MC; Shu CW; Wann SR; Liu CP; Tseng CJ; Huang WC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909527
[TBL] [Abstract][Full Text] [Related]
17. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
Molecules; 2018 May; 23(6):. PubMed ID: 29861433
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
